|
List of principal contributors |
|
|
ix | |
|
|
xiii | |
Preface |
|
xv | |
SECTION I: DIAGNOSIS |
|
|
|
|
Role of capsule encoscopy in Crohn's disease |
|
|
3 | (4) |
|
|
Endoscopy in Crohn's disease |
|
|
7 | (7) |
|
|
Colitis diagnosis and therapeutic strategies -- how, what and when to biopsy |
|
|
14 | (11) |
|
|
SECTION II: MICROSCOPIC COLITIS |
|
|
|
|
|
Epidemiology of microscopic colitis |
|
|
25 | (8) |
|
|
Microscopic colitis: histological classification |
|
|
33 | (12) |
|
|
|
|
|
Mechanisms of pathogenesis in microscopic colitis |
|
|
45 | (7) |
|
|
Microscopic colitis: treatment |
|
|
52 | (11) |
|
|
SECTION III: PREDICTING OUTCOMES |
|
|
|
|
|
Predicting the natural history of inflammatory bowel disease |
|
|
63 | (7) |
|
|
Can we predict who develops extraintestinal manifestations? |
|
|
70 | (7) |
|
|
Colitis: predicting outcomes -- who gets cancer? |
|
|
77 | (10) |
|
|
SECTION IV: CORTICOSTEROID THERAPY |
|
|
|
|
|
Mechanisms of steroid action and resistance in inflammatory bowel disease |
|
|
87 | (11) |
|
|
|
Budesonide for ulcerative colitis |
|
|
98 | (13) |
|
|
|
How do I use steroids in Crohn's disease? |
|
|
111 | (9) |
|
|
Why corticosteroids should not be used as first-line therapy for Crohn's disease |
|
|
120 | (9) |
|
|
|
|
|
|
Azathioprine: molecular mechanism of action |
|
|
129 | (6) |
|
|
Pharmacogenetics of azathioprine - useful in clinical practice? |
|
|
135 | (7) |
|
|
|
Azathioprine: long-term side-effects |
|
|
142 | (10) |
|
|
State-of-the-Art Lecture: Trials and complications of ileal pouch surgery |
|
|
152 | (31) |
|
|
|
SECTION VI: IMMUNOMODULATORY THERAPY |
|
|
|
|
|
Biologics in ulcerative colitis |
|
|
183 | (10) |
|
|
|
SECTION VII: CANCER AND IBD |
|
|
|
|
|
Diagnosis of colitis associated dysplasia: new colonoscopic techniques |
|
|
193 | (12) |
|
|
|
Can we prevent cancer using current drugs? |
|
|
205 | (15) |
|
|
Management of low-grade dysplasia in inflammatory bowel disease |
|
|
220 | (6) |
|
|
Low-grade dysplasia in flat mucosa: is it relevant? |
|
|
226 | (9) |
|
|
SECTION VIII: NEW THERAPEUTIC APPROACHES |
|
|
|
|
|
|
235 | (6) |
|
|
Helminths and immune modulation of inflammatory bowel disease |
|
|
241 | (9) |
|
|
|
Probiotics for inflammatory bowel disease |
|
|
250 | (11) |
|
Index |
|
261 | |